Tactics for type I diabetes

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This article discusses the evolution of therapy for type I diabetes and considers how physicians should be thinking about the disease in the late 1990s. The biases herein are that management strategy has evolved such that contemporary practice should routinely entail a system of 'flexible intensive therapy' directed at meticulous glycemic control. To accomplish this requires a skilled management team including an educated, motivated patient and family working in a negotiated therapeutic alliance; a further goal should be the development of effective approaches to interdict the pathogenetic process such that disease prevention is possible.

Original languageEnglish
Pages (from-to)647-657
Number of pages11
JournalEndocrinology and Metabolism Clinics of North America
Volume26
Issue number3
DOIs
StatePublished - Oct 8 1997

Fingerprint

Medical problems
Type 1 Diabetes Mellitus
Therapeutics
Physicians

ASJC Scopus subject areas

  • Endocrinology
  • Biochemistry

Cite this

Tactics for type I diabetes. / Skyler, Jay S.

In: Endocrinology and Metabolism Clinics of North America, Vol. 26, No. 3, 08.10.1997, p. 647-657.

Research output: Contribution to journalArticle

@article{6adbc74a3dc94fcf8557bfc940760c8e,
title = "Tactics for type I diabetes",
abstract = "This article discusses the evolution of therapy for type I diabetes and considers how physicians should be thinking about the disease in the late 1990s. The biases herein are that management strategy has evolved such that contemporary practice should routinely entail a system of 'flexible intensive therapy' directed at meticulous glycemic control. To accomplish this requires a skilled management team including an educated, motivated patient and family working in a negotiated therapeutic alliance; a further goal should be the development of effective approaches to interdict the pathogenetic process such that disease prevention is possible.",
author = "Skyler, {Jay S}",
year = "1997",
month = "10",
day = "8",
doi = "10.1016/S0889-8529(05)70272-3",
language = "English",
volume = "26",
pages = "647--657",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Tactics for type I diabetes

AU - Skyler, Jay S

PY - 1997/10/8

Y1 - 1997/10/8

N2 - This article discusses the evolution of therapy for type I diabetes and considers how physicians should be thinking about the disease in the late 1990s. The biases herein are that management strategy has evolved such that contemporary practice should routinely entail a system of 'flexible intensive therapy' directed at meticulous glycemic control. To accomplish this requires a skilled management team including an educated, motivated patient and family working in a negotiated therapeutic alliance; a further goal should be the development of effective approaches to interdict the pathogenetic process such that disease prevention is possible.

AB - This article discusses the evolution of therapy for type I diabetes and considers how physicians should be thinking about the disease in the late 1990s. The biases herein are that management strategy has evolved such that contemporary practice should routinely entail a system of 'flexible intensive therapy' directed at meticulous glycemic control. To accomplish this requires a skilled management team including an educated, motivated patient and family working in a negotiated therapeutic alliance; a further goal should be the development of effective approaches to interdict the pathogenetic process such that disease prevention is possible.

UR - http://www.scopus.com/inward/record.url?scp=0030843397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030843397&partnerID=8YFLogxK

U2 - 10.1016/S0889-8529(05)70272-3

DO - 10.1016/S0889-8529(05)70272-3

M3 - Article

C2 - 9314020

AN - SCOPUS:0030843397

VL - 26

SP - 647

EP - 657

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 3

ER -